RxDoctor Payments Data

Rebecca Jaiyesimi

Psychiatric/Mental Health · Sherman, TXNPI 1619677473

Payments from drug & device makers

$4,071in general payments, 2019–2025

Across 196 payments — averaging $20.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Alkermes, Inc.$520
  • Otsuka America Pharmaceutical, Inc.$510
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$358
  • Teva Pharmaceuticals USA, Inc.$285
  • Lundbeck LLC$173
  • plus $1K from 20 others

What the payments were for

  • Food & beverage$4,058100%
  • Education$130%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,071 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl44$65,877
RexultiBrexpiprazole25$40,021
Risperdal ConstaRisperidone Microspheres11$23,916
TrintellixVortioxetine Hydrobromide18$18,170
BelsomraSuvorexant32$13,372
Paliperidone ErPaliperidone13$8,546
Duloxetine Hcl204$3,730
Aripiprazole161$3,597
Quetiapine Fumarate193$3,200
Lamotrigine235$2,263
Buspirone Hcl158$2,069
Mirtazapine150$2,029
Vilazodone Hcl12$1,990
Bupropion Hcl SrBupropion Hcl184$1,964
Hydroxyzine Hcl72$1,801

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,052$65,87744 claims
Otsuka America Pharmaceutical, Inc.Rexulti$510$40,02125 claims
Johnson & JohnsonRisperdal Consta$52$23,91611 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$84$18,17018 claims
MerckBelsomra$24$13,37232 claims
Almatica Pharma LLCSertraline Hcl$32$959166 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Sherman

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →